Explore more topics
SEC reporting owner

HBM Healthcare Investments (Cayman) Ltd. SEC insider disclosures

Explore HBM Healthcare Investments (Cayman) Ltd.'s reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-14T07:26:40.310Z

Reporting owner CIK
0001232258
Issuers
11
Coverage
verified
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 11 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

MICRUS ENDOVASCULAR CORP0001028318MENDNoNo
Pacira Pharmaceuticals, Inc.0001396814PCRXNoNo
PTC THERAPEUTICS, INC.0001070081PTCTNoNo
Ophthotech Corp.0001410939OPHTNoNo
LPATH, INC0001251769LPTNNoNo
Paratek Pharmaceuticals, Inc.0001178711PRTKNoNo
Nabriva Therapeutics plc0001641640NBRVNoNo
Nabriva Therapeutics Legacy plc0001703287NBRVNoNo
Werewolf Therapeutics, Inc.0001785530HOWLNoNo
IO Biotech, Inc.0001865494IOBTNoNo
Mineralys Therapeutics, Inc.0001933414MLYSNoNo
MICRUS ENDOVASCULAR CORP ↗Pacira Pharmaceuticals, Inc. ↗PTC THERAPEUTICS, INC. ↗Ophthotech Corp. ↗LPATH, INC ↗Paratek Pharmaceuticals, Inc. ↗Nabriva Therapeutics plc ↗Nabriva Therapeutics Legacy plc ↗Werewolf Therapeutics, Inc. ↗IO Biotech, Inc. ↗Mineralys Therapeutics, Inc. ↗

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.